Dextrose 20% Injection USP (2016-03-02)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 49075JT | - Recalling Firm
- Hospira Healthcare Corporation
- 2600 Alfred-Nobel Bvld, Suite 500
- Saint-Laurent
- H4S 0A9
- Quebec
- CANADA
- Marketing Authorization Holder
- Hospira Healthcare Corporation
- 2600 Alfred-Nobel Bvld, Suite 500
- Saint-Laurent
- H4S 0A9
- Quebec
- CANADA
| Dextrose 20% Injection USP | Solution | DIN 00037966 | Dextrose 200 mg/mL |
Affected Products
Dextrose 20% Injection USP
Recall due to a potential contact with foreign substance during manufacturing.
Hospitals (including Pharmacies), Wholesalers